spacer
home > epc > winter 2003 > automation in a validated environment fuels big business rewards
PUBLICATIONS
European Pharmaceutical Contractor

Automation in a Validated Environment Fuels Big Business Rewards

Integrated building management solutions incorporating comprehensive electronic record keeping and signature capabilities can go a long way to fulfilling the pharmaceutical industry's threefold mantra of regulatory compliance, productivity gain and faster time-to-market. Never before has there been so much emphasis on the environment within which critical-to-quality processes for pharmaceuticals, biotechnology products and medical devices take place. In research labs, manufacturing areas and warehouses, conditions such as temperature, humidity, pressure, air particulate levels and access must be monitored, safely archived and easily retrieved for reporting purposes and audit - local, European and US Food & Drug Administration (FDA) audit alike.

But how is it best to implement compliant environmental control in a complex and mission-critical framework? Pharmaceutical manufacturers across Europe are always hungry for new, smarter ways of working. I am asked the same questions wherever I go:

How can we use raw data feeds to eliminate internal bottlenecks?
How can we make the shift from paper-based to automated, electronic records and signature?
How can we use building automation technology to refine processes, reduce costs and speed time-to-market?
How can we integrate FDA-compliant environmental control solutions into an enterprise-wide pharmaceutical operation?


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Walfried Laibacher, Validation Services Leader at Honeywell, Europe

Walfried Laibacher, Dipl-Ing (FH), is the Validation Service Leader for Honeywell in Europe. Based in Offenbach, Germany, he oversees Honeywell's specialist validation sales and engineering teams. Since joining Honeywell in 1988, Walfried has held several positions in software development from Software Engineer to Project Leader for HVAC and building management solutions. He is a regular on the European lecture circuit, his speciality being new-generation validation solutions and integrated building automation systems.

spacer
Walfried Laibacher
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Destiny Pharma appoints MedPharm to develop new XF-platform drug formulations

Destiny Pharma, a clinical stage biotechnology company focused on the development of novel antimicrobial drugs, is pleased to announce that it has appointed MedPharm as its expert partner to develop new topical formulations of the Company’s novel XF-platform compounds. These new treatments for dermal and ocular infections are part of its second clinical programme to address the global problem of anti-microbial resistance (AMR). MedPharm is a world leading contract provider of topical and transdermal product design and formulation development services using sophisticated in vitro models to de-risk development programmes.
More info >>

White Papers

Orthogonal Approaches for the Analysis of Protein Sequence

Ludger Ltd

One of the most important classes of biopharmaceuticals is monoclonal antibodies. They are expressed from living cells, and are consequently subject to complex biochemical pathways. Not all of these routes are fully understood, and many are sensitive to the subtlest of environmental changes. Changes such as these can affect the final biopharmaceutical sequence, structure and post-translational modifications, not to mention any changes that may occur during further purification. This often means that the final product from one batch may be different from the last in another batch. Each batch is a complicated mix of similar molecules, and analysis of the degree of batch-to-batch variation is therefore very important to the establishment of the drug's safety for medicinal use and patient administration.
More info >>

 
Industry Events

The Universe of Pre-filled Syringes and Injection Devices

22-23 October 2019, The Swedish Exhibition & Congress Centre Gothia Towers Hotel

PDA’s Universe of Pre-filled Syringes and Injection Devices has become the must-attend meeting for everyone working in the field, and is now the world’s largest conference on this subject
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement